Article info
PDFOriginal article
Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma
- Correspondence to Dr Michelle R Downes, Department of Pathology and Laboratory Medicine, University Health Network, 200 Elizabeth Street, Toronto, ON, Canada M5G 2C4; michelle.downes{at}uhn.ca
Citation
Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma
Publication history
- Received February 27, 2013
- Revised May 13, 2013
- Accepted May 14, 2013
- First published June 17, 2013.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions